News Dong-A ST Co., Ltd.

Equities

A170900

KR7170900005

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
67,600 ^KRW	+0.45%		-2.31%	-2.17%

Mar. 18	Dong-A ST Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 24	GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dong-A ST Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.	Jan. 23	CI
FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara	Jan. 05	CI
Dong-A ST Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
MEZOO Co.,Ltd. announced that it has received KRW 18 billion in funding from a group of investors	Nov. 06	CI
Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on July 26, 2023.	23-10-19	CI
Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on July 26, 2023.	23-10-19	CI
Dong-A ST Co., Ltd.'s Equity Buyback announced on July 26, 2023, has closed with 38,373 shares, representing 0.45% for KRW 2,296.31 million.	23-10-16	CI
Dong-A ST Sets Sight on European Market with Stelara Biosimilar Expansion	23-08-31	MT
Dong-A ST Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Dong-A ST Co., Ltd. announces an Equity Buyback for 38,373 shares.	23-07-26	CI
Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on April 26, 2023.	23-07-25	CI
Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on April 26, 2023.	23-07-25	CI
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	23-07-25	CI
EMA Accepts MAA for DMB-3115 of Dong-A ST, a Stelara Biosimilar	23-07-17	CI
Dong-A ST Co., Ltd.'s Equity Buyback announced on April 26, 2023, has closed with 45,872 shares, representing 0.54% for KRW 2,520.87 million.	23-07-16	CI
Dong-A ST Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Dong-A ST Co., Ltd. announces an Equity Buyback for 45,872 shares.	23-04-26	CI
Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on January 26, 2023.	23-04-26	CI
Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on January 26, 2023.	23-04-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Dong-A ST Co., Ltd.

Equities

A170900

KR7170900005

Summary

Filters